George, Gincy, et al. “Risk of Cardiovascular Events in Men on Abiraterone or Enzalutamide Combined With GnRH Agonists: Nation-Wide, Population-Based Cohort Study in Sweden”. Acta Oncologica, vol. 60, no. 4, Apr. 2021, pp. 459-65, doi:10.1080/0284186X.2021.1885058.